Facts and News
Financial highlights

1,663,016
BGN '000 Revenues 2022

139,980
BGN '000 EBITDA 2022
Stock performance
Bulgarian Stock Exchange
Warsaw Stock Exchange
Corporate News
23 October 2018

Corporate News
28 October 2021


Corporate News
23 October 2018

Corporate News
28 October 2021

Stories
Business & Markets
The state-of-the-art solid dosage forms manufacturing facility of Sopharma AD in Sofia.